Clinical Scorecard: Exploring the Role of the Gut Microbiome in HIV Reservoir Behavior
At a Glance
Category
Detail
Condition
HIV infection with persistent viral reservoirs despite ART
Key Mechanisms
Gut microbiome dysbiosis alters immune activation and gut barrier integrity, influencing HIV reservoir dynamics
Target Population
People with HIV (PWH) on antiretroviral therapy
Care Setting
HIV clinical management and research settings focusing on reservoir and microbiome interactions
Key Highlights
HIV reservoirs persist in the gastrointestinal tract despite ART, contributing to chronic immune activation and comorbidities.
Gut microbiome dysbiosis in HIV leads to impaired gut barrier, microbial translocation, and systemic inflammation.
Microbial composition and HIV reservoir size vary along the gastrointestinal tract with complex, segment-specific associations.
Guideline-Based Recommendations
Diagnosis
Consider gastrointestinal tract sampling beyond stool and rectal swabs for accurate microbiome and HIV reservoir assessment.
Management
Maintain ART to control HIV replication but recognize persistent reservoirs and immune activation.
Investigate microbiome-targeted interventions to modulate immune activation and reservoir dynamics.
Monitoring & Follow-up
Monitor immune activation markers and gut microbiome composition as potential indicators of reservoir behavior and treatment response.
Risks
Persistent microbial translocation and dysbiosis contribute to chronic inflammation, T-cell exhaustion, and increased morbidity.
Proinflammatory microbiome profiles may both facilitate viral control and impair immunotherapy efficacy.
Patient & Prescribing Data
People with HIV on ART with persistent viral reservoirs
Baseline gut microbiome composition may influence viral rebound timing and response to immunotherapies such as latency-reversing agents and cytokine therapies.
Clinical Best Practices
Recognize the gastrointestinal tract as a critical site for HIV reservoir persistence and immune activation.
Account for confounding factors affecting the gut microbiome including diet, sexual behavior, and ART regimen.
Use comprehensive sampling approaches for microbiome and reservoir studies to capture segment-specific dynamics.
Consider the dual role of proinflammatory microbiomes in both viral control and potential immunotherapy resistance.
